Overview


According to FutureWise analysis, the market for Flow Cytometry is to reach US$ 4,652.78 million in 2022, and is expected to grow at a CAGR of 8.2% over the forecast period of 2023-2031.

Flow cytometry is an incredibly advanced technology that offers an unparalleled analysis of individual cells in a liquid sample. Utilizing lasers to measure both the physical and chemical properties of cells as they pass through a narrow channel, this technology provides a comprehensive understanding of a cell's crucial attributes, such as cell surface markers, internal components, and DNA content. The laser-generated signals enable researchers to delve deeper into cell biology, opening up new possibilities for scientific discovery.

The uses of flow cytometry are vast and diverse, with applications in many areas, including research, clinical diagnostics, and drug development. In research settings, flow cytometry is a valuable method for studying cellular pathways and discovering drug targets. It's great for analyzing cancer and immune cells, identifying cell types, and evaluating drug candidates. In clinical diagnostics, flow cytometry is used to diagnose and monitor a range of diseases, including leukemia, lymphoma, and HIV. It can also be used to monitor immune responses to infection or vaccination. For example, flow cytometry can be used to measure the levels of certain immune cells in the blood or to identify abnormal cells in a biopsy sample. In drug development, flow cytometry can be used to screen large libraries of compounds for activity against specific targets. This tool can assess the effectiveness and safety of possible medications. For example, flow cytometry can be used to analyze the effects of a drug on the growth and behavior of cancer cells or to evaluate the impact of a drug on immune cell function.

FutureWise Market Research has published a report that provides an insightful analysis of Flow Cytometry Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Flow Cytometry Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Becton, Dickinson and Company
  • Beckman Coulter (A Subsidiary of Danaher)
  • Thermo Fisher Scientific
  • Luminex Corporation
  • Merck KGaA
  • Luminex Corporation
  • Agilent Technologies
  • Cytonome/St, LLC Laboratories
  • Sony Biotechnology (A Subsidiary of Sony Corporation of America)
  • Sysmex Partec (A Subsidiary of Sysmex Corporation)
  • Miltenyi Biotec
  • Cytonome/St, LLC
  • Stratedigm, Inc.
  • Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem)
  • Biomérieux SA
  • Cytonome/St, LLC
  • Stratedigm, Inc.
  • Apogee Flow Systems
  • Cytek Biosciences, Inc.
  • Sartorius AG
  • Union Biometrica, Inc.
  • Nanocellect Biomedical, Inc.
  • On-Chip Biotechnologies Co., Ltd.

Recent developments by key players in Flow Cytometry Market:

In November 2022, The SFA—Life Sciences Cloud Platform, developed by Sony Corporation, is a cloud-based tool for the analysis of flow cytometry data that makes it simple to locate uncommon cells, such as cancer cells and stem cells, in a variety of cell populations. This is accomplished using data from flow cytometers.

The market for flow cytometry has been experiencing a gradual increase over the past few years, driven by a combination of increasing applications across multiple fields, technological advancements, and growing demand for personalized medicine. The development of high-throughput systems in flow cytometry has brought about remarkable technological advancements that enable the concurrent analysis of vast quantities of cells with ease. This has significantly increased the efficiency of flow cytometry and has broadened its application in research, clinical diagnostics, and drug development. In addition to technological advancements, the increasing demand for personalized medicine has also been driving the growth of the flow cytometry market. Flow cytometry is increasingly being used to identify and analyze individual cells, allowing for the development of personalized treatments that are tailored to the unique characteristics of each patient. The rise of cancer research and the increasing prevalence of infectious diseases, autoimmune disorders, and chronic diseases are also contributing to the expansion of the flow cytometry market. The ability of flow cytometry to rapidly and accurately analyze large numbers of cells has made it an essential tool in the diagnosis, prognosis, and treatment of these diseases. Moreover, the increasing investment in life sciences research and development by both government and private organizations is further driving the growth of the flow cytometry market. With the increasing demand for advanced technologies to support research, flow cytometry is expected to continue experiencing significant growth in the coming years.

Although the flow cytometry market has a positive outlook, it faces obstacles that impede its expansion. These include the high cost of equipment and reagents, scarcity of competent professionals, and stringent regulatory demands. However, with the increasing demand for personalized medicine and the continued advancement of technology, the market's upward trend is expected to persist despite any obstacles it may encounter.

By Technology 

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

By Product and Service 

  • Reagents and Consumables
  • Instruments
    • Cell Analyzers
      • High-range
      • Mid-range
      • Low-range
    • Cell Sorters
      • High-range
      • Mid-range
      • Low-range
  • Services
  • Software
  • Accessories

By Application

  • Research Applications
    • Pharmaceuticals and Biotechnology
      • Drug Discovery
      • Stem Cell Research
      • In Vitro Toxicity Testing
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other Research Applications
  • Clinical Applications
    • Cancer Diagnostics
    • Hematology
    • Immunodeficiency Diseases
    • Organ Transplantation
    • Other Clinical Applications
  • Industrial Applications

By End User

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
  • Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. During the forecast period, significant growth is inevitable for the region owing to escalated research, higher occurrences of leishmania and HIV, and the existence of major market players. The incidence of leishmaniasis in Mexico has increased, making it crucial to determine a patient's prognosis through flow cytometry. This method has become more significant with the development of tests that detect the disease and assess drug resistance. For instance, an article in the Tropical Medicine and Infectious Disease journal from December 2022 reported an increase in leishmania cases over the past five years. As the number of people with leishmaniasis continues to grow, there is likely to be an increased demand for flow cytometry to accurately assess prognosis in the coming years. Therefore, in the forecast period, the region is set to experience a significant expansion, driven by the increasing prevalence of leishmania and HIV, as well as the strong efforts in research and development and the introduction of new products. Additionally, based on end-user; the academic & research institutes segment accounts for the largest market share in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Flow Cytometry Market By Technology, By Product and Service, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Flow Cytometry Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview

    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Flow Cytometry Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Flow Cytometry Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Flow Cytometry Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cell-based Flow Cytometry
        2. Bead-based Flow Cytometry

  • 8.   Flow Cytometry Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Reagents and Consumables
        2. Instruments
         2.1. Cell Analyzers
          2.1.1. High-range
          2.1.2. Mid-range
          2.1.3. Low-range
         2.2. Cell Sorters
          2.2.1. High-range
          2.2.2. Mid-range
          2.2.3. Low-range
        3. Services
        4. Software
        5. Accessories

  • 9.   Flow Cytometry Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Research Applications
         1.1. Pharmaceuticals and Biotechnology
          1.1.1. Drug Discovery
          1.1.2. Stem Cell Research
          1.1.3. In Vitro Toxicity Testing
         1.2. Immunology
         1.3. Cell Sorting
         1.4. Apoptosis
         1.5. Cell Cycle Analysis
         1.6. Cell Viability
         1.7. Cell Counting
         1.8. Other Research Applications
        2. Clinical Applications
         2.1. Cancer Diagnostics
         2.2. Hematology
         2.3. Immunodeficiency Diseases
         2.4. Organ Transplantation
         2.5. Other Clinical Applications
        3. Industrial Applications

  • 10.   Flow Cytometry Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Academic and Research Institutes
        2. Hospitals and Clinical Testing Laboratories
        3. Pharmaceutical and Biotechnology Companies

  • 11.   North America Flow Cytometry Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Flow Cytometry Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Flow Cytometry Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Flow Cytometry Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Becton, Dickinson and Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Beckman Coulter (A Subsidiary of Danaher)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Luminex Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Agilent Technologies
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Sony Biotechnology (A Subsidiary of Sony Corporation of America)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cytonome/St, LLC Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Miltenyi Biotec
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem).
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Sysmex Partec (A Subsidiary of Sysmex Corporation)
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Biomérieux SA
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Cytonome/St, LLC
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Stratedigm, Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Apogee Flow Systems
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Cytek Biosciences, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.Sartorius AG
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        18.Union Biometrica, Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.Nanocellect Biomedical, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20.On-Chip Biotechnologies Co., Ltd.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11